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Structures of the CCR5 N Terminus
and of a Tyrosine-Sulfated Antibody
with HIV-1 gp120 and CD4
The CCR5 co-receptor binds to the HIV-l gp120 envelope glycoprotein and facilitates HIV-l entry into
cells. Its N terminus is tyrosine-sulfated, as are many antibodies that react with the co-receptor binding
site on gp120. We applied nuclear magnetic resonance and crystallographic techniques to analyze the
structure of the CCR5 N terminus and that of the tyrosine-sulfated antibody 412d in complex with
gp120 and CD4. The conformations of tyrosine-sulfated regions of CCR5 (a-helix) and 412d (extended-
loop) are surprisingly different. Nonetheless, a critical sulfotyrosine on CCR5 and on 412d induces
similar structural rearrangements in gp120. These results now provide a framework for understanding
HIV-l interactions with the CCR5 N terminus during viral entry and define a conserved site on gp120,
whose recognition of sulfotyrosine engenders posttranslational mimicry by the immune system.
EnUy of hwnan immunodeficiency virustype I (HIV-1) into host cells requires itsgpl20 envelope glycoprotein to bind to
two cell-surface receptors, CD4 and a co-
receptor, either CCRS or CXCR4 [reviewed in
(1, 2)]. CCRS and CXCR4 are members of a
family of chemokine receptors that are G
protein-eoupled receptors (3) characterized by
seven transmembrane helices, an extracellular N
terminus, which is variable in length, and three
extracellular loops (ECLs) (Fig. lA). The struc-
ture of the co-receptor has not been determined,
but some insight has come from the crystal struc-
tures of other family members (4).
Elements critical to interactions with HIV-I are
located in the co-receptor N terminus and around
its second extracellular loop (ECL2) (5-8). The
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co-receptor N terminus interacts with a highly
conserved 4-stranded bridging sheet in gp120,
which assembles upon CD4 binding, whereas the
ECL2 region of the co-receptor interacts with the
tip of the irnmunodominant V3 loop in gp120.
Considerable distance separates these two inter-
active regions, which suggests that they are in-
dependent (9-12).
The N-terminal interaction of co-receptor
with HIV-I requires an unusual posttranslational
modification, O-sulfation of tyrosine (13). On
CCRS, tyrosines at residues 3, 10, 14, and IS
may be O-sulfated, but sulfations at residues 10
and 14 are sufficient to facilitate interaction with
HIV-I (14). Interestingly, many CD4-induced anti-
bodies that react with the bridging sheet region
are also modified by O-sulfation (15). To define
structurally the interaction of HIV-l with the N
terminus of CCRS and to understand the molec-
ular details of the mimicry of this interaction by
CD4-induced antibodies, we used a combination
of nuclear magnetic resonance (NMR) and x-ray
crystallography to determine the structures of the
N terminus of CCRS and of a functionally sul-
fated antibody, 412d, in complex with HIV-l gp120.
Analysis ofthese structures, combined with molec-
ular docking and saturation transfer difference
NMR, identified a conserved site on gp120, which
recognizes sulfotyrosine with high selectivity.
We used NMR techniques that exploit the
transfer of information from bound to ligand-free
states (16, 17) to analyze the interactions ofa 14-
residue peptide (CCRS2- 15), which consisted of
residues 2 to IS of CCRS with sulfotyrosine
(Tys) at positions 10 and 14 (Fig. I) (18). We
collected two-dimensional (2D) nuclear Over-
hauser enhancement spectroscopy (NOESY)
spectra of solutions containing CCRS2- 15 either
free or in the presence of gp120, CD4, or a
gp120-CD4 complex (peptide:protein ratio of
40:1). Whereas spectra containing free CCRS2- 15
or CCRS2- 15 with either gpl20 or CD4 contained
few cross peaks, CCRS2- 15 in the presence of the
gp120-CD4 complex gave rise to high-quality
spectra containing nwnerous NOEs (Fig. lB and
fig. S1). Complete IH, 13C, and 15N assignments
ofCCRS2-15 (table SI) were made on the basis of
standard 2D homonuclear and heteronuclear
NMR experiments that measure scalar and di-
polar couplings.
The NOESY data of CCRS2- 15 in the pres-
ence of gp120-CD4 (Fig. lB) were sufficient for
calculating a high quality ensemble of NMR
structures (Fig. 1C). Structure calculations were
carried out on the ordered region comprising
residues 7 to IS. A total of70 distance restraints
(corresponding to 3S intraresidue and 3S inter-
residue NOEs), and S6 dihedral angle restraints
were included in the final round of structure
calculations, which gave rise to an ensemble of
40 structures with a backbone root-mean-square
deviation (rmsd) of0.46 A and an rmsd of 1.39 A
for all atoms in the ordered region (residues 9 to
14) (table S2). Superpositions of the fmal ensem-
ble defined a helical conformation for residues 9
to IS, which deviated from the ideal by a back-
bone rrnsd of only 0.26 A (Fig. lD). Sulfotyro-
sines 10 and 14 extended from the same face of
the helix, with sulfate moieties separated by ~loA
and an ~90° rotation around the helix axis.
We were unable to obtain crystals ofCCRS2-15
in complex with HIV-l gpI20-CD4, and the size
and glycosylation of the ternary complex hin-
dered direct determination by NMR. We were,
however, able to obtain ~3.S A diffraction from
crystals of the antigen-binding fragment (Fab) of
the 412d antibody, in complex with gp120 (core
with V3, CCRS-dependent isolate YU2) and
CD4. The 412d antibody is functionally tyrosine-
sulfated, binds to a CD4-induced epitope that
overlaps the site of co-receptor binding on HIV-
I gp120, and recognizes preferentially CCRS-
dependent strains ofHIV-l gpl20 (15). Moreover,
the tyrosine-sulfated region of 412d can be sub-
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stituted for the tyrosine-sulfated region of CCR5
to create a chimeric 412d/CCRS receptor that sup-
ports HIV-1 entry (19).
We solved the 412d-gp120-CD4 structure by
molecular replacement. Despite less than optimal
resolution and completeness, initial unbiased
maps showed clear defmition of important anti-
body features (fig. S2). Structure refmement re-
sulted in an ReryS! of 20% (Rfree 27%) (Fig. 2,
table S3, and fig. S3). The overall mode of
binding of 412d resembles that of 17b, which
shares a heavy chain of similar genomic origin
(fig. S4) (20). A hydrophobic interaction pins the
second complementarity-determining region of
the heavy chain (CDR H2) to a conserved hydro-
phobic surface on the bridging sheet of gp120,
whereas the acidic CDR H3 binds a basic gp120
surface. Antibody 412d, however, interacts with
a much larger overall surface area than either 17b
or X5 (fig. S4). The increased 412d interaction
surface is due primarily to an increase in buried
surface associated with its CDR H3. Comparison
of free (20) and bound structures of 412d shows
that extensive ordering occurs in CDR H3 when
bound to gp120 (fig. S5).
The two sulfotyrosines in the CDR H3 region
of 412d bind to gp120 in quite different ways
(Fig. 2). The sulfotyrosine at residue 100 of412d
(Tys 100412d) [Kabat numbering (21)] is mostly
exposed, with its aromatic ring making 1t-cation
interactions with the guanidinium of Arg
327gp120 and its sulfate group making only
peripheral electrostatic interactions. By contrast,
the side-chain ofTys 100C412d is mostly buried,
with Ile 322gp120 and De 326gp120 embracing one
face of the tyrosine ring, while the aliphatic base
of Arg 440gp120 supports the other. Together, the
two sulfotyrosines account for about 20% of the
total buried surface on 412d, with almost 100 A2
derived from Tys 100C412d.
To facilitate interactions with the sulfotyro-
sines in 412d, the V3 stem is rearranged. The
conserved Arg 29Sgp120 and Pro 299gp120 at the
base of the V3 loop are mostly unchanged, but
the subsequent Asn residues at 301gp120 and
302gp120 shift ~7 A to form one wall of the Tys
100c4I 2d sulfate-binding pocket. Residue
301 gp120 is N-glycosylated, but the glycan faces
solvent, and its presence should have little impact
on the ability of the binding pocket to form.
Meanwhile, in the returning strand (22), De
A
2 10 14 20 32
DYQVSSPIYDINYYTSEPCQKINVKQlAARL
N
+ gp120-C04
CCR52-15 »- CCR52-15_gp120-C04
2.0
1.0
e-
o.
4.0.90
LL
7.0
8.0
3.0
&.. •
.J
.....
"_ '1·- li~ ,~
...
-
.
.. ,
.
...
'. li ;
0 .... 0~~ 4. .••.. ~u:
7·-.::t··r" ~•/" '.NH-NH, {aromatic
{
.0.~ .
NH-CaH .:.~i' _. .
- ..oIt..- -' - -If- -
B
I
55
I
ECL3
CCR52-15
Intracellular
-55-
ECl1 ECL2
c
8.5 8.0 7.5 7,0 6.5 8,5 8.0 7,5 7.0 6.5
F2 (ppm)
c
Fig, 1. Structure of the tyrosine-sulfated Nterminus of CCRS in the gp120-
bound conformation. (A) CCRS sequence and schematic of its insertion in
the cell membrane. Sequence letters in purple correspond to residues in
CCRS 2-15, with sulfotyrosines (Tys) critical for interaction with HIV-1 high-
lighted in black. ECls are labeled, and disulfide bridges (-55-) depicted. (8)
20 NOE5Y spectra for CCRS 2-15 free in solution (left) and in the presence of
gp12D-CD4 (right). NMR samples (20 mM phosphate, 50 mM NaCl, pH
6.85) contained 800 ~M CCRS2-15 in the presence of 20 ~M gp120-CD4 and
were recorded at 500 MHz, 300 K, mixing time = 150 msec. Sequential
NH(O-(aH(i-1) NOEs were observed between every residue, thereby confirming
sequential assignments, and predicted intra residue NOEs were observed for
all residues. No correlations beyond sequential NOEs were observed between
residues 2 and 7, indicating that this region of CCRS was extended or
disordered. In contrast, NOEs from CaH(Ii to NH(i + 1,2,3) and from NH(Ii to
NH(i + 1,2,3) were observed for residues 9 to 15 (fig. 51), indicating an
ordered a-helical structure (33). (e) Structure of the ordered region of
gp120-bound CCRS2-15• 5tereoview (left) of 25 lowest energy-simulated
annealing structures superimposed by fitting to the backbone of residues 9
to 15. Structural statistics are provided in table 52. Backbone appears in
blue, amide hydrogens (9 to 15) in blue, side chains (11 to 13) in green, and
Tys 10 and Tys 14 in red. Ribbon diagram (right) of restrained minimized
mean structure with side chains in stick representations.
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A B Fig. 2. Structure of the tyrosine-sulfated antibody 412d in
complex with HIV-1 gp120 and CD4. (A) Ribbon representa-
tion. CD4 is yellow, the heavy chain of Fab 412d is dark
blue, the light chain is cyan, and gp120 is gray, except for
the V3 loop, which is orange. The CDR H3 loop of 412d is
red, with sulfotyrosines depicted in stick representation. (8)
Close-up, with molecular surface of gp120 in gray and
sulfotyrosines of 412d (red labels) and select residues of
gp120 (black labels) in stick representation. Dotted lines
represent coordinating hydrogen bonds between gp120 and
the sulfate group of Tys100C412d . The sulfate of Tys 100C412d
makes a full complement of ionic interactions: a salt bridge
to Arg 2989P120 and hydrogen bonds to the side-chain
nitrogen of Asn 3029P120, the side-chain hydroxyl of Thr
3039P120, and the main-chain amides of 3029P120, 3039P120,
and 4419P120 (34).
B c
7:0 6:9 6:8 6:7
1H (ppm)
CCRS·bound (ECL2)
...... ~
CCRS·bound (N·terminus + ECL2)CD4-boundUnliganded
E
'"-£ '"~ fQ
o 8'
.$ ~ <J.5f§' ~ '!l:'A ~'Acf
.§ 8 8 8.§
11. 11. II 1I.}l.
~ ~ ~ ~ ~ii ~ ii r;: Q
0; 0; 0; 0; 0; Uncleaved
_ j9P120
:r-Cleaved
\
9P120
CD4
D
100kDa
75
50=:::::= -37~
25--
1S--:::::
10 .........
Fig. 3. Interaction of the N terminus of CCRS with HIV-1 gp120-CD4. (A)
Molecular docking. The 20 lowest energy structures (black) from 200 docking
runs of CCRS2-15 are shown in stick representation. Despite initial random
orientations, all favorable docking solutions had Tys 14 binding at the bridging
sheet-V3 interface; none had Tys 10 at this cleft. Ribbon representations illustrate
CD4 in yellow, gp120 in gray (with V3 in orange), and the lowest energy structure
of CCRS7-15 in purple. (8) Close-up, with molecular surface of gp120 in gray and
select residues of gp120 (black labels) and CCRS (purple labels) in stick
representation. (() Saturation transfer difference NMR spectrum of CCRS2-15 in
the presence of gp12Q-CD4 (red) overlaid on a control 1H spectrum (black).
Experimental conditions were identical to those used for NOE experiments,
except that the carrier was set at -1 and SO parts per million for on- and off-
resonance saturation, respectively. The intensities of the most strongly enhanced
peaks (Tys 14 and Tyr 1S) have been normalized to the corresponding signals in
the control spectrum. Peak assignments made by 2D NMR (table 51) appear
above their corresponding doublet signals. Tys 14 and Tyr 1S show strong
CCR5-bound (N-terminus)
saturation transfer difference effects, whereas Tys 10 shows a medium effect and
Tyr 3 a very weak effect. These effects correlate directly with the buried surface
area of each tyrosine ring in the docked structure. See fig. 59 for overlaid spectra
employing 1 to 7 s saturation. (D) Effect of CCRS2-15 on the proteolytic sensitivity
of the V3. Electrophoresis on an 8 to 2S% gradient SDS polyacrylamide gel shows
the results of thrombin digestion on gp120 (core with V3; YU2 RS strain of HIV-1)
alone, or in the presence of sCD4 or sCD4 and CCRS2-15 (35). (E) Structural
intermediates of HIV-1 entry. At far left, a single monomer of unliganded
gp120 (gray) is shown with separated [3-hairpins. The threefold axis, from
which gp41 interacts in the functional oligomer, is labeled with the number 3.
In the CD4-bound state, the bridging sheet assembles, and the V3 (orange) is
exposed and flexible. The next state involves either (upper pathway) the
interaction of the CCRS-ECL2 region with the V3 tip or (lower pathway) the
interaction of the CCRS N terminus, which induces rigidification of the V3
stem. Engagement of CCRS at both N terminus and ECL2 region triggers
additional conformational changes leading to HIV-1 entry.
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Bound V3Unbound V3
Fig. 4. A conserved
site for binding sulfotyro-
sine on HIV-l gp120.
(A) Alterations of the V3
base to accommodate
binding of sulfotyrosine.
The gp120 (gray) region
around the V3 loop (or-
ange) is illustrated in
ribbon diagram, with an
overlying semitrans-
parent surface for un-
bound (left paneO and
bound (right paneO con-
formations. Binding of
the CCR5 N terminus
(purple) or the 412d CDR H3 (red), each with two sulfotyrosines (stick
representation, with red and purple labels), alters the V3 base, forming a
sulfotyrosine binding pocket and a rigid ~-hairpin. (B) Close-up of the conserved
sulfotyrosine binding pocket. The orientation shown is similar to that in Figs. 2B
and 3B [-90° from (A) about a diagonal axis, as defined by the long axis of the V3
from (A)]. Tys 14CCR5 is shown in purple, with Tys 100C412d in red. Select residues
of gp120 are shown in stick representation and labeled in black. Hydrogen bonds
coordinating the buried sulfate groups in each are depicted with dotted lines.
322gp120 shifts 10 A to encase the 100C412d tyro-
sine ring. Overall, the incoming and outgoing
strands ofthe V3 stem are brought closer together,
so that a ~-hairpin is formed that replaces the pre-
viously flexible V3 stem (23). Thus, whereas most
of the gp120-CD4 complex remains unchanged,
binding of sulfotyrosine at the bridging sheet-V3
interface results in formation ofa more rigid V3.
By employing molecular docking and satura-
tion transfer difference NMR, we sought to use
the 4l2d-gp120-CD4 structure to ascertain how
gp120 interacts with the N terminus of CCRS.
We fIrst tested whether docking [Autodock 3.0
(24)] of the CDR H3 loop of 4l2d to gp120
would recapitulate the 4l2d-gp120 crystal struc-
ture. Starting from random initial positions and
orientations, multiple runs of the excised CDR
H3 loop (residues 97 to lOOt) produced an ener-
getically favorable interaction (-16.04 kcal/mol),
which closely resembled its location and contacts
in the crystal structure (Co rmsd between crystal
and docked CDR H3 was 1.03 A) (fIg. S6). We
next docked the NMR structure of the CCRS N
terminus to the crystal structure of gp120-CD4.
Multiple runs produced a cluster of energetically
favorable solutions (-17.60 kcal/mol for the
optimal solution), which placed CCRS2-15 at the
bridging sheet-V3 interface (Fig. 3, A and B).
The top 10% of the solutions (20 best solutions
from 200 runs) had rmsds of 1.04 A (Co) and
2.24 A (all atoms).
To validate the docked CCRS-gp120 structure,
we performed saturation transfer difference NMR
(17) on CCRS2-15 in the presence ofgp120-CD4.
Control and difference spectra are shown in Fig. 3C.
Contact surfaces ofTys and Tyrresidues ofCCRS
in the docked orientation correlated well with satu-
ration transfer difference enhancements (Fig. 3C).
We also observed good correlation between inter-
acting residues in the docked gp120-CCRS inter-
face and gp120 and CCRS substitutions (9, 25-27)
that affect gp120-CCRS binding (fIg. S7).
The N terminus of CCRS approaches from
the same face of gp120 as CD4 but binds to an
orthogonal surface at the intersection of the
bridging sheet and the V3 loop (Fig. 3). The fust
CCRS residues (Ser 7 and Pro 8) that are ordered
in the NMR structure interact with the V3 stem.
In the helix (residues 9 to IS), Tys 10 interacts
with the gp120 core and forms a salt bridge with
Arg 327gp120, Asp 11 forms an ionic interaction
with Arg 440gp120, Tys 14 is completely seques-
tered in the crevice between V3 and the bridging
sheet, and the aromatic ring of Tyr IS packs
against Ile 439gp 120 on the bridging sheet.
The structural rearrangements required to
form the Tys 14 binding pocket would be
expected to rigidifY the V3 stem. We tested V3-
proteolytic susceptibility (Fig. 3D). CD4 en-
hances V3-proteolytic susceptibility to thrombin
(28,29), whereas the combination ofCD4 and
CCRS2-15 reduced proteolytic susceptibility
(Fig. 3D), consistent with CCRS-rigidifIcation
ofV3.
Overall, the gp120 recognition surface for
CCRS2-15 is much more highly conserved for
CCRS-dependent isolates compared with those
that use CXCR4. Good electrostatic comple-
mentarity is found between the acidic CCRS2-15
and gp120, where the negatively charged C-
terminal helix dipole is oriented toward the basic
bridging sheet (fIg. S8). The docked structure
provides an explanation for the observed lack of
order at the N terminus ofCCRS2-15, where CCRS
appears to extend away from gp120. At the C ter-
minus, Tyr IS points toward the target cell mem-
brane where, in fIve residues, a disulfIde would
normally be made between the N terminus (Cys
20) and the third extracellular loop (Cys 269).
Despite the higWy divergent tyrosine-sulfated
structures of4l2d and CCRS, a single sulfotyro-
sine (residue 100c in 4l2d and residue 14 in
CCRS) is recognized in a similar manner by
gp120 (Fig. 4). We used mutagenesis to probe the
degree of similarity in this recognition (fIg. S10).
The alteration of a single nitrogen in a contact
residue (Asn302Asp) in the conserved binding
pocket ablates recognition ofboth 4l2d and CCRS,
whereas a similar substitution (Asn300Asp), just
outside the binding pocket, had little effect (30).
The observed convergence of recognition likely
reflects the high selectivity of this site for sulfo-
tyrosine (a 7 A deep pocket, with hydrophobic
walls and a cationic floor, which is unlikely to
interact favorably with other nonmodifIed amino
acids). Such selectivity and favorable energetics
bode well for design of therapeutics targeted at
this site, because the gp120 residues that line the
sulfotyrosine binding pocket are highly con-
served for co-receptor binding.
The structure of the CCRS N terminus with
gp120-CD4 provides a further snapshot of the
HIV-l entry pathway (Fig. 3E). Before binding
CD4, the bridging sheet is not formed and the V3
loop is occluded. Binding ofCD4 induces bridg-
ing sheet assembly and V3 exposure. At this
stage, the V3 is flexible and poised close to the
target cell membrane. Subsequent interactions
with CCRS are still being elucidated. We show
structural details for one: engagement by gp 120
of the CCRS N terminus, which requires
formation ofa conserved pocket for sulfotyrosine
binding and converts the flexible V3 stem into a
rigid ~-hairpin. It will be interesting to integrate
the order and timing of the rearrangements
revealed here into the HIV-l entry mechanism.
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